Efficacy and Safety of VM202 in Painful Diabetic Peripheral Neuropathy -The HOPES Trial

Summary

A double-blind, randomized, placebo-controlled, single-center, 12-month phase 2 study designed to assess the safety and efficacy of VM202 as a replacement for opioid analgesics in opioid-tolerant subjects with painful diabetic peripheral neuropathy (DPN).

Timeline

Start

2019-11

Primary completion

2022-12

Completion

2022-12

Outcome

Outcome not reported

Stopped (Enrollment): “This study never left the planning stages: there was no IRB application and no participants were enrolled.”

Drugs

Indications